文献速递精神分裂症与精神病性障碍

精神分裂症未用药个体两个独立队列中临床相关但纹状体多巴胺合成能力未升高

Clinical correlation but no elevation of striatal dopamine synthesis capacity in two independent cohorts of medication-free individuals with schizophrenia.
PubMed 文献 · Mol Psychiatry · 2021-11-17

研究对两个独立的精神分裂症谱系障碍未用药队列进行盲法停药后[18F]-FDOPA PET成像,评估纹状体多巴胺合成能力。两个队列中患者与匹配健康对照组均无显著差异,但阴性症状严重程度与示踪剂特异性摄取在纹状体广泛区域呈稳健负相关且可重复。

要点

  • 两个独立未用药精神分裂症谱系队列中,纹状体多巴胺合成能力与健康对照无显著差异。
  • 阴性症状越重,纹状体[18F]-FDOPA特异性摄取越低,该负相关在两个队列中可重复。
  • 作者认为纹状体多巴胺过度活跃可能并非部分个体原发性精神病 définitive 特征。

核心结论

  • 对于部分个体,纹状体多巴胺过度活跃可能不是原发性精神病 définitive 或持续存在的特征。
  • 个体间临床差异可能与纹状体多巴胺能张力变异显著相关。
  • 这些发现需要进一步实验以解析精神分裂症多巴胺系统功能的异质性。

研究设计与样本

  • 研究纳入两个独立的精神分裂症谱系障碍个体队列,均接受盲法停药后未用药状态下的[18F]-FDOPA PET神经影像检查以评估纹状体多巴胺合成能力。
  • 每个患者队列均与匹配的健康对照组进行比较。

主要发现

  • 两个队列中,患者与匹配健康对照组之间纹状体多巴胺合成能力均无显著差异。
  • 在两个队列中均发现并重复了阴性症状严重程度与示踪剂特异性摄取在纹状体广泛区域的稳健负相关:阴性症状更突出的患者[18F]-FDOPA特异性摄取更低。
  • 补充的体素水平和感兴趣区分析,无论是否进行部分容积校正,均得到一致结果。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Dysregulation of dopamine systems has been considered a foundational driver of pathophysiological processes in schizophrenia, an illness characterized by diverse domains of symptomatology. Prior work observing elevated presynaptic dopamine synthesis capacity in some patient groups has not always identified consistent symptom correlates, and studies of affected individuals in medication-free states have been challenging to obtain. Here we report on two separate cohorts of individuals with schizophrenia spectrum illness who underwent blinded medication withdrawal and medication-free neuroimaging with [18F]-FDOPA PET to assess striatal dopamine synthesis capacity. Consistently in both cohorts, we found no significant differences between patient and matched, healthy comparison groups; however, we did identify and replicate robust inverse relationships between negative symptom severity and tracer-specific uptake widely throughout the striatum: [18F]-FDOPA specific uptake was lower in patients with a greater preponderance of negative symptoms. Complementary voxel-wise and region of interest analyses, both with and without partial volume correction, yielded consistent results. These data suggest that for some individuals, striatal hyperdopaminergia may not be a defining or enduring feature of primary psychotic illness. However, clinical differences across individuals may be significantly linked to variability in striatal dopaminergic tone. These findings call for further experimentation aimed at parsing the heterogeneity of dopaminergic systems function in schizophrenia.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Eisenberg DP, Kohn PD, Hegarty CE, et al. Clinical correlation but no elevation of striatal dopamine synthesis capacity in two independent cohorts of medication-free individuals with schizophrenia. Mol Psychiatry. 2021. PMID: 34789848. doi:10.1038/s41380-021-01337-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。